Table 3.
Medication use at baseline.
| Medications | Total (N=102), n (%) | Control (n=51), n (%) | Endocare (n=51), n (%) | P value | |
| Analgesics | |||||
|
|
Anilides | 15 (14.7) | 10 (19.6) | 5 (9.8) | .26 |
|
|
Natural opium alkaloids | 3 (2.9) | 1 (2.0) | 2 (3.9) | >.99 |
|
|
Opioids in combination with antispasmodics | 2 (2.0) | 0 (0.0) | 2 (3.9) | .50 |
|
|
Opioids in combination with nonopioid analgesics | 8 (7.8) | 5 (9.8) | 3 (5.9) | .72 |
|
|
Other analgesics and antipyretics | 10 (9.8) | 5 (9.8) | 5 (9.8) | >.99 |
|
|
Other opioids | 3 (2.9) | 0 (0.0) | 3 (5.9) | .24 |
|
|
Salicylic acid and derivatives | 1 (1.0) | 1 (2.0) | 0 (0.0) | >.99 |
| Other antiemetics and antinauseants | 1 (1.0) | 0 (0.0) | 1 (2.0) | >.99 | |
| Other antiepileptics | 0 (0.0) | 0 (0.0) | 0 (0.0) | >.99 | |
| Anti-inflammatory and antirheumatic products | |||||
|
|
Fenamates | 0 (0.0) | 0 (0.0) | 0 (0.0) | >.99 |
|
|
Propionic acid derivatives | 26 (25.5) | 12 (23.5) | 14 (27.5) | .82 |
| Proton pump inhibitors (for acid-related disorders) | 0 (0.0) | 0 (0.0) | 0 (0.0) | >.99 | |
| Other drugs for functional gastrointestinal disorders | 6 (5.9) | 4 (7.8) | 2 (3.9) | .68 | |